Name | ATX inhibitor 17 |
---|
Description | ATX inhibitor 17 is a potent ATX inhibitor with an IC50 of 0.019 µM. ATX inhibitor 17 shows excellent anti-proliferative activities in breast cancer cells[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.019 µM (ATX)[1] |
In Vitro | ATX inhibitor 17 (compound 25a) (0-15 µM; 72 h) shows excellent anti-proliferative activities in breast cancer cells[1]. Cell Cytotoxicity Assay[1] Cell Line: MCF7, MDA-MB-231, A549, H2228 cells Concentration: 0-15 µM Incubation Time: 72 h Result: Showed excellent antiproliferative effects with IC50s of 1.01, 0.79, 13.40, >15 µM for MCF7, MDA-MB-231, A549, H2228 cells, respectively. |
References |
Molecular Formula | C29H29F5N8S |
---|---|
Molecular Weight | 616.65 |